Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Cladribine exerts an immunomodulatory effect on human and murine dendritic cells.
Monocytes P2X7 purinergic receptor is modulated by glatiramer acetate in multiple sclerosis.
Immunosuppressive properties of mesenchymal stem cells: advances and applications.
Treatment of progressive multiple sclerosis: what works, what does not, and what is needed.
Forward Pharma Receives Decision to Grant From EPO for DMF Patent in Europe
Effect of Glatiramer Acetate on Peripheral Blood Brain-Derived Neurotrophic Factor and Phosphorylated TrkB Levels in Relapsing-Remitting Multiple Sclerosis.
T cell regulation mediated by interaction of soluble CD52 with the inhibitory receptor Siglec-10.
Alemtuzumab benefits hard-to-treat MS patients
Amyloid fibrils activate B-1a lymphocytes to ameliorate inflammatory brain disease.
Impact of cladribine therapy on changes in circulating dendritic cell subsets, T cells and B cells in patients with multiple sclerosis.
The N-terminal pro-brain natriuretic peptide as a marker of mitoxantrone-induced cardiotoxicity in multiple sclerosis patients.
Comparative pharmacokinetics and pharmacodynamics of recombinant human interferon beta-1a after intramuscular and subcutaneous administration.
Neuroprotection with glatiramer acetate: evidence from the PreCISe trial.
Effects of 2-Chlorodeoxyadenosine (Cladribine) on Primary Rat Microglia.
Phase III study with teriflunomide versus placebo in patients with first clinical symptom of multiple sclerosis (TOPIC)
Randomized, comparative study of interferon beta-1a treatment regimens in MS: The EVIDENCE Trial.
The scales and tales of myelination: using zebrafish and mouse to study myelinating glia.
Multiple Sclerosis and Pregnancy: Current Considerations.
The Swiss Multiple Sclerosis Cohort-Study (SMSC): A Prospective Swiss Wide Investigation of Key Phases in Disease Evolution and New Treatment Options.
Evaluation of pattern-reversal visual evoked potential in patients with neuromyelitis optica.
Incidence of infusion-associated reactions with rituximab for treating multiple sclerosis: a retrospective analysis of patients treated at a US centre.
Persisting myelin oligodendrocyte glycoprotein antibodies in aquaporin-4 antibody negative pediatric neuromyelitis optica.
Immunomodulatory therapeutic effect of glatiramer acetate on several murine models of inflammatory bowel disease.
Biogen Third Quarter 2015 Revenues Increase 11% to $2.8 Billion; Company Raises 2015 Full Year Guidance
Inflammatory cortical demyelination in early multiple sclerosis.

Pages